Decision spine
Frames the controlling thesis, evidence status, buyer implications, and research-use limits.
Emerging Med Tech
Zemi Dossier
Research-use only
Xenotransplantation Durability Ceiling
A decision package on why more edits do not automatically buy more organ time in xenotransplantation.
Decision this dossier helps answer
Which xenotransplantation programs are limited by host tolerance, organ-specific failure physiology, perfusion, or immune compatibility rather than edit count?
Problem this dossier solves
More edits do not guarantee more time.
The dossier reframes xenotransplantation around the organ’s durability ceiling: host response, graft physiology, vascular integrity, and organ-specific failure. It helps buyers identify which barrier still controls survival after genetic engineering.
What is moving: current field evidence and platform activity
What is unresolved: decision-grade proof, endpoint logic, and failure modes
What Zemi solves: evidence-gated next-study strategy
Full decision package
112-page research report plus 45-sheet Evidence & Decision Workbook
Buy now
$3,500$5,500Launch price
Controlling thesis
More edits do not guarantee more time.
The dossier reframes xenotransplantation around the organ’s durability ceiling: host response, graft physiology, vascular integrity, and organ-specific failure. It helps buyers identify which barrier still controls survival after genetic engineering.
A Zemi Dossier turns uncertain emerging research into a decision package: what is known, what is inferred, what is hypothetical, what would falsify the thesis, and what should be built, funded, avoided, monitored, or validated next.
Research report preview
First 30 pages of the actual Xenotransplantation Durability Ceiling research report.
The public page shows the real document style, density, evidence posture, and decision framing before a buyer requests access to the full Zemi Dossier package.
Research report
The research report is the argument. It is not the whole product.
The PDF research report is the structured argument: field status, evidence maturity, buyer implications, falsifiable hypotheses, power-calculated next studies, strategic recommendations, limitations, and traceability posture.
Inspectable infrastructure
Pairs the report with claim ledgers, evidence tables, power rows, audit surfaces, and decision tools.
Executable next studies
Links hypotheses to endpoint logic, assumptions, sample-size logic, budget, and timeline planning.
Research report table of contents
Public TOC generated from the source report.
The full research report is delivered as a licensed PDF. This table shows the decision structure without publishing the full product.
| Section | What it covers | Buyer value |
|---|---|---|
| Decision Brief Read This First | Turns the report into immediate buyer triage: what matters now, what is still uncertain, and what to do next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Contents | Shows the report structure and where to inspect the argument, evidence, workbook logic, and limits. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Executive Summary | Condenses the dossier thesis, evidence posture, buyer implications, and next-study priorities. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Scope and Evidence Integrity | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| Decision Snapshot Overview | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buy Build Wait Avoid | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Buyer Decision Matrix | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Source Quality Dashboard | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Lets the buyer audit support strength before relying on the package. |
| The Durability Ceiling Ledger | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The Durability-Ceiling Ledger: time-to-failure as a host-bounded, organ-specific bottleneck | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The six laws of the Ledger (sharpened against the 2026 frontier) | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The keystone: the DCHR host-risk classifier | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| The three hard questions the dossier resolves | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The Dchr Host Risk Classifier | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| The DCHR host-risk classifier (reusable proprietary asset; research-use only) | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| The Dchr Archetype Walkthrough | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| The DCHR archetype walkthrough: six worked cases | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Current Signal Refresh 2025 2026 | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross Organ Convergence Map | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross-organ / cross-domain convergence map | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross Domain Synthesis Expanded | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Cross-domain synthesis: the connections no single field makes | Shows how separate research signals converge, diverge, or interact across domains, mechanisms, or study layers. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Evidence Maturity Matrix | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Comparative Platform Mechanism Matrix | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| Key Findings | Summarizes the most decision-relevant findings and their implications for the dossier thesis. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Host-bound ceiling | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Edit-insensitivity | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Organ-timescale law | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Shared amplifier | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Proximal complement | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Liver coagulopathy | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Kidney TMA/proteinuria | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Recipient-driven rejection | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Tolerance is the ceiling-raiser | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Net-survival frontier | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| Species pharmacology | Connects research maturity to competitive position, program strategy, and diligence watchpoints. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
Evidence & Decision Workbook
The workbook is the decision engine.
A locked public preview of selected workbook-derived sheets: sheet structure, decision modules, power rows, traceability, and audit posture. Licensed buyers receive the full workbook files.
Read-only workbook preview with clipped values and no formulas. Licensed buyers receive the full Evidence & Decision Workbook with editable assumptions and working files.
Workbook inventory
Delivered workbook sheets.
Full inventories belong on dossier pages, not the homepage. Sheet names below are extracted from the actual workbook file.
| # | Workbook sheet | What it does |
|---|---|---|
| 1 | 1. Workbook Guide | Navigation layer for using the workbook, understanding sheet roles, and following the decision package. Public preview exposes Hypotheses, 14: 5 Flagship + 5 Frontier + 4. fields and clipped entries such as Executable modules, The DCHR Classifier., Seven. |
| 2 | 2. Claim Ledger | Claim-by-claim ledger showing verdicts, source support, inference status, and decision relevance. Public preview exposes claim_id, claim_text, report_section, report_page fields and clipped entries such as S1, United Therapeutics is recruiting a., Edit-count. |
| 3 | 3. Evidence Table | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes Identifier, Title, Journal/Source, Year fields and clipped entries such as DOI:10.3389/fcell.2026.1835561, Transplantation immunology: paradigm.,. |
| 4 | 4. Source-Support Verdicts | Independent check on whether key claims are actually supported by cited sources. Public preview exposes Finding, Label, Verdict, Primary cite fields and clipped entries such as S1, Finding 1 — United Therapeutics is., SUPPORTS_EXACTLY. |
| 5 | 5. Source Quality Summary | Summary of source strength, gaps, and areas where conclusions depend on weaker evidence. Public preview exposes Claims audited, 97 fields and clipped entries such as Source-kept, Excluded (all off-topic). |
| 6 | 6. Evidence Maturity Matrix | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes Failure-mode axis, Human evidence, Mechanism, Functional/TTF fields and clipped entries such as AMR (recipient Ab), Mod (n=1-2 living), High. |
| 7 | 7. TTF Organ-Physiology Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S6, Finding 6 — Genetically modified pig., Genetically modified pig kidneys.. |
| 8 | 8. TMA-Complement Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S26, Finding 26 — In xenotransplantation,., In xenotransplantation, advances.. |
| 9 | 9. AMR - Recipient-Risk Tracker | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S4, Finding 4 — SLA-DR knockout pigs on a., SLA-DR knockout pigs on a.. |
| 10 | 10. Infection - IS Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S2, Finding 2 — After pig-to-baboon., After pig-to-baboon kidney.. |
| 11 | 11. Tolerance-Induction Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S21, Finding 21 — A Phase 1/2 trial., A Phase 1/2 trial (NCT07224763) is.. |
| 12 | 12. Donor-Genetics Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as S1, Finding 1 — United Therapeutics is., United Therapeutics is recruiting a.. |
| 13 | 13. Surveillance-Biomarker Trac | Tracks biomarkers or readouts that determine whether the thesis is moving toward testable evidence. Public preview exposes Finding, Label, Claim, Grade fields and clipped entries such as V23, RRI identifies TMA before creatinine., Functional surveillance. |
| 14 | 14. TTF - Survival Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Case / program, Organ, Edit count (sponsor), Time-to-failure fields and clipped entries such as Slayman (living human), kidney, 69 (eGenesis). |
| 15 | 15. Trial - Catalyst Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes NCT, Title, Status, Phase fields and clipped entries such as NCT05340426, Porcine Kidney Xenotransplantation., WITHDRAWN. |
| 16 | 16. Company - Sponsor Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes Company, Asset, Modality, Organ fields and clipped entries such as United Therapeutics (Revivicor), 10 GE Xenokidney (UKidney), gene-edited porcine. |
| 17 | 17. Safety - Risk Tracker | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes Rescue=Risk: every DCHR decision. fields from this sheet. |
| 18 | 18. Biomarker - Endpoint Tracke | Tracks biomarkers or readouts that determine whether the thesis is moving toward testable evidence. Public preview exposes Chimerism / Tregs, Tolerance status, -, DCHR input [PMID 41513041] fields and clipped entries such as Time-to-failure, Graft survival,. |
| 19 | 19. Regulatory Tracker | Tracks regulatory, endpoint, reimbursement, or qualification requirements that shape testing strategy. Public preview exposes Question, Status / channel, Note fields and clipped entries such as US living-patient xeno to date, FDA Expanded Access., NOT. |
| 20 | 20. Hypotheses Ledger | Maps hypotheses to evidence state, falsification logic, endpoints, and next-study design. Public preview exposes Hypothesis, Tier, Paradigm, Primary endpoint (TTF where. fields and clipped entries such as F1 - Host-failure-mode-matched., Flagship,. |
| 21 | 21. Most-Valuable Next Studies | Prioritizes next studies that could change the decision, including endpoints and evidence gates. Public preview exposes #, Study, Tests, Primary endpoint fields and clipped entries such as Host-mode-matched vs baseline (F1), the Ledger + DCHR, graft TTF. |
| 22 | 22. Validation - Falsification | Connects proposed validation work to falsification criteria, readouts, and decision gates. Public preview exposes IS-minimization improves net., N1 / Law 5, competing-endpoint model, more IS improves net survival fields and clipped entries such as. |
| 23 | 23. Figure Source Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes figure_id, figure_title, figure_family, section_anchor fields and clipped entries such as fig01_grade_recalibration, Claim-level grade. |
| 24 | 24. Figure Attempt Ledger | Figure and numeric reproduction log for validating calculations, chart inputs, or displayed values. Public preview exposes Figure ID, Backend, Status, Limitation note fields and clipped entries such as fig01_grade_recalibration, deterministic, PASS. |
| 25 | 25. Verification - Search Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Source/DB, Query, Hits fields and clipped entries such as pubmed, pig kidney xenotransplantation gene., pubmed. |
| 26 | 26. Excluded Claims | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes Label, Bucket, Citations, Disposition fields and clipped entries such as Excluded 1 — Acute rejection affects., off-topic,. |
| 27 | 27. Quarantine Register | Disposition log for rejected, bounded, or quarantined claims so they do not leak into the decision thesis. Public preview exposes PMID:39960350 / PMID:39960355, retracted, Two on-topic 2025., EXCLUDED — never cited; logged so. fields and clipped entries such. |
| 28 | 28. Traceability Certificate | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes claim_id, report_section, report_page, claim_text fields and clipped entries such as S1, Edit-count natural experiment, United. |
| 29 | 29. Score Basis | Explains how scores or ratings were assigned so the decision instrument can be inspected. Public preview exposes fig10 maturity matrix, 0-4 (none..V.high), per axis x dimension; cited. fields and clipped entries such as fig11 strategy matrix, 0-4,. |
| 30 | 30. Power Calculations | Power-calculation layer for assumptions, endpoint logic, computed sample sizes, and sensitivity checks. Public preview exposes hypothesis_id, study_id, endpoint, test_type fields and clipped entries such as F1, MVNS-01, Host-mode-matched vs baseline - TTF. |
| 31 | 31. Competitive Landscape | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes company, asset, organ, edit_count fields and clipped entries such as United Therapeutics (Revivicor), 10 GE Xenokidney (UKidney), kidney. |
| 32 | DCHR_Input_Template | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Immunosuppression-vs-infection., IS intensity, PCMV/PRV + PERV., ____ fields and clipped entries such as Tolerance-induction status, chimerism,. |
| 33 | DCHR_Feature_Score | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes INFECTION-UNDER-IS-DOMINANT, Competing endpoint: IS intensity., 1, 1.1 fields and clipped entries such as ORGAN-PHYSIOLOGY-DOMINANT, Organ-specific. |
| 34 | DCHR_Class_Output | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Evidence completeness (ENTER 0-1), 0.8 fields and clipped entries such as Organ (ENTER kidney/liver/heart/lung), kidney, OUTPUT CLASS. |
| 35 | DCHR_Decision_Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Class (binding mode), Matched host strategy, Time-to-failure endpoint, Required safety readout fields and clipped entries such as AMR-DOMINANT,. |
| 36 | DCHR_Minimum_Assay_Panel | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Assay / readout, Axis, Tier fields and clipped entries such as Pre-formed anti-pig antibody titer, Recipient immune risk, Required. |
| 37 | DCHR_Archetype_Cards | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Archetype, Profile (risks), Binding mode, Matched host move fields and clipped entries such as AMR-dominant (sensitized recipient), AMR 3, rest. |
| 38 | DCHR_Validation_Log | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Validation cohort, DCHR-classified living xeno. fields and clipped entries such as Held-out AUC target, >= 0.80, Failure threshold. |
| 39 | DCHR_Traceability_Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes DCHR element, Maps to claim/finding, Evidence ID, Figure fields and clipped entries such as AMR axis, recipient stratification, PMID. |
| 40 | 32. PDF Number Register | Workbook surface supporting a specific evidence, decision, study-planning, or release-control workflow. Public preview exposes #, rendered_number_or_identifier, report_context, claim_id fields and clipped entries such as Ceiling: Host Tolerance,., V26,. |
| 41 | 33. Figure Reproduction Notes | Figure and numeric reproduction log for validating calculations, chart inputs, or displayed values. Public preview exposes figure_id, data_type, source_rows, exact_workbook_cells_or_fields fields and clipped entries such as fig01_grade_recalibration,. |
| 42 | 34. Formula Audit | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes sheet, cell, formula, cached_value_written fields and clipped entries such as 30. Power Calculations, J3,. |
| 43 | 35. Currentness Scan | Monitoring surface for emerging signals, update triggers, and evidence changes that could alter the decision. Public preview exposes company_or_program, asset_or_signal, edit_count, status fields and clipped entries such as live currentness scan timestamp,. |
| 44 | 40. Version Registry | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes v1.0, June 2026, Initial premium Tier C build from., Claude (Opus 4.8) fields and clipped entries such as v1.1 visual-remediation,. |
| 45 | 41. Audit Issues Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Issue, Status, Resolution fields and clipped entries such as AI-1, Workbook genuinely executable?, RESOLVED. |
Power-calculated next studies
Power calculations are the execution bridge.
Power calculations are planning-grade research calculations for endpoint logic, assumptions, sample size, budget, and timeline. They do not prove hypotheses or constitute clinical protocol.
| Hypothesis | Primary endpoint | Test | Effect | α | Power | Computed n | Design n |
|---|---|---|---|---|---|---|---|
| F1 | Host-mode-matched vs baseline - TTF | survival/log-rank | 0.55 | 0.05 | 0.80 | 88 | 110 |
| F2 | Tolerance (thymokidney) vs fixed-edit - TTF | survival/log-rank | 0.5 | 0.05 | 0.80 | 66 | 83 |
| F3 | Proximal C3 blockade - TMA-free survival | two-proportion (pooled) | 0.65 | 0.05 | 0.80 | 62 | 62 |
| F4 | Edit-insensitivity (log-TTF by edit tier) | two-sample means (Cohen's d) | 0.5 | 0.05 | 0.80 | 63 | 63 |
| F5 | Host-risk stratifier vs donor genetics - AUC | AUC (Hanley-McNeil, external) | 0.78 | 0.05 | 0.80 | 55 | 110 |
Release audit discipline
Audit posture is part of the product.
Public pages do not publish exact audit scores. They should state the release discipline, revision posture, and limitations without implying peer review or validated clinical guidance.
Research-use decision package
Not medical advice, clinical guidance, investment advice, or a clinical protocol.
Known / inferred / hypothetical
The package separates cited evidence from inference and frontier hypothesis generation.
Audit-gated and revision-controlled
Adversarial audit checks source support, formulas, figures, limitations, and release readiness.
Buy this dossier
Full decision package — 112-page report + 45-sheet workbook
Buy now
- Decision research report (112 pages, PDF)
- Evidence & Decision Workbook (45 sheets, .xlsx) — claims, source-support verdicts, power calculations, traceability, and audit log
- Live, editable power-calculated next studies
$3,500$5,500Launch price